Figure 2
Distributions of targeted measurements of C-mannosyltryptophan and pseudouridine and their fractional excretion in individuals with and without CKD. (A) Plasma concentrations, (B) Urine concentrations, (C) Fractional excretion.
Figure 2 | Scientific Reports
